ĢƵAPP

Skip to content
Human Health

The Future of Health Starts Before Disease Does

For more than a century, medicine has been organized around a familiar sequence: symptoms emerge, a diagnosis is made, and treatment begins. 

That model has produced extraordinary advances in human health. But today, advances in AI, data science, diagnostics, and our understanding of biology are creating the possibility of a different model, one in which we identify disease earlier and intervene before it progresses. 

The opportunity is not simply to make healthcare more predictive. It is to make health preemptive. 

Moving the intervention point upstream 

Many of the diseases responsible for the greatest burden on human health develop over years or decades. Yet healthcare often encounters them relatively late, after symptoms appear or disease crosses a diagnostic threshold. 

A preemptive approach moves the intervention point upstream. It asks whether we can detect meaningful changes earlier, identify the people most likely to benefit from intervention, and act while there is still an opportunity to change their health trajectory. 

AI is expanding what may be possible here. Healthcare systems already generate enormous amounts of information through routine care. New approaches can potentially uncover signals within that existing data that reveal disease or risk that would otherwise remain hidden. 

But earlier detection is only valuable if we can act on it – and if we can do so at scale. 

A novel partnership that advances detection and intervention together 

That principle is at the center of a new collaboration between Flagship Labs 113 and Virta Health, the leader in reversing metabolic disease. FL113, a ĢƵAPP-founded company in stealth, has developed a platform that can identify hidden and undiagnosed disease from existing health data. Working with Virta, FL113 will initially focus on improving outcomes associated with cardiometabolic conditions including metabolic dysfunction-associated steatotic liver disease (“MASLD”) and metabolic dysfunction-associated steatohepatitis (“MASH”) by pairing its AI-enabled health insights with Virta’s nutrition-based intervention platform. 

The ambition goes beyond finding disease earlier. For risk-bearing healthcare organizations – including payers, accountable care organizations, integrated delivery systems, and self-funded employers – the ability to identify at-risk populations and connect them to appropriate interventions earlier could create a new lever for improving both health and economic outcomes. Instead of waiting for disease progression to drive greater clinical complexity and healthcare utilization, organizations could potentially act earlier, when there is a greater opportunity to alter the trajectory.  

That captures what we believe is essential to realizing preemptive health: detection and intervention must advance together. Finding disease earlier is not the endpoint. The goal is to create an actionable window in which patients, providers, and the organizations responsible for population health have an opportunity to change what happens next. 

From predicting disease to changing its trajectory 

The shift toward preemptive health will require more than increasingly sophisticated prediction. It will require systems that connect biological insight to interventions, and demonstrate that acting earlier can deliver measurable value across populations. 

If successful, that shift could change not only when we address disease, but how healthcare organizations manage health: moving from responding to costly disease progression toward identifying opportunities to preserve health earlier. 

At Flagship, we see this as an important frontier in medicine: moving from treating established disease toward identifying and addressing it at earlier, more actionable stages. 

Ultimately, the measure of progress will not be how much earlier we can predict disease. 

It will be whether earlier identification empowers people to change their health trajectory, and live longer, healthier lives. 

Story By

Raj Panjabi

Raj Panjabi is responsible for leading Flagship’s Preemptive Health and Medicine Initiative, which is pioneering a new field to protect, maintain, or improve people’s health before they get sick. Raj is former White House Senior Director and…

Armen Mkrtchyan

Armen Mkrtchyan is an Origination Partner at ĢƵAPP where he leads a team to invent and launch new breakthrough platform companies grounded in Artificial Intelligence (AI).Armen brings a strong entrepreneurial spirit and depth of…

More from: Human Health